CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes

S-C Sun1

  • 1Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. ssun@mdanderson.org

Insights

Cylindromatosis (CYLD) is a deubiquitinase (DUB) that suppresses tumors by inhibiting NF-kappaB signaling. CYLD removes K63-linked ubiquitin chains, preventing cell survival and oncogenesis.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • Protein ubiquitination is a reversible post-translational modification crucial for cellular processes.
  • Deubiquitinases (DUBs) are enzymes that remove ubiquitin chains, regulating protein function.
  • CYLD is a tumor suppressor DUB implicated in regulating NF-kappaB signaling.

Purpose of the Study:

  • To elucidate the role of CYLD in regulating NF-kappaB activation.
  • To understand the mechanism by which CYLD exerts its tumor suppressor function.
  • To explore the broader physiological functions regulated by CYLD.

Main Methods:

  • Investigating the deubiquitinase activity of CYLD.
  • Analyzing the interaction between CYLD and NF-kappaB signaling pathway components.
  • Studying the impact of CYLD on NF-kappaB activation in cellular models.

Main Results:

  • CYLD deconjugates K63-linked ubiquitin chains involved in NF-kappaB activation.
  • CYLD negatively regulates NF-kappaB signaling, contributing to its tumor suppressor activity.
  • CYLD influences diverse processes including immune response, inflammation, and cell cycle.

Conclusions:

  • CYLD plays a critical role in negatively regulating NF-kappaB signaling.
  • CYLD's function as a tumor suppressor is linked to its control over NF-kappaB.
  • CYLD is a key regulator of multiple physiological pathways, highlighting its broad importance.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...